The use of clinical risk factors enhances the perfomance of BMD in the prediction of hip and osteoporotic fractures in men and women.
DSpace/Manakin Repository
The use of clinical risk factors enhances the perfomance of BMD in the prediction of hip and osteoporotic fractures in men and women.
Kanis, J.A.; Oden, A.; Johnell, O.; Johansson, H.; de Laet, C.; Brown, J.; Burckhardt, P.; Cooper, C.; Christiansen, C.; Cummings, S.; Eisman, J.A.; Fujiwara, S.; Gluer, C.; Goltzman, D.; Hans, D.; Krieg, M.A.; La Croix, A.; McCloskey, E.; Mellstrom, D.; Melton, L.J.; Pols, H.A.; Reeve, J.; Sanders, K.; Schott, A.M.; Silman, A.; Torgerson, D.; van Staa, T.P.; Watts, N.B.; Yoshimura, N.
(2007) Osteoporosis International, volume 18, pp. 1033 - 1046
(Article)
Download/Full Text
Open Access version via Utrecht University Repository
Publisher version
Keywords: Farmacie/Biofarmaceutische wetenschappen (FARM), Epidemiology, Farmacie(FARM), Biomedische technologie en medicijnen, Ziekenhuisstructuur en organisatie van de gezondheidszorg, Public Health
ISSN: 0937-941X
Publisher: Springer
(Peer reviewed)
See
more statistics
about this item